About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2014 (2014), Article ID 312647, 8 pages
http://dx.doi.org/10.1155/2014/312647
Research Article

Infliximab Reverses Suppression of Cholesterol Efflux Proteins by TNF-α: A Possible Mechanism for Modulation of Atherogenesis

Winthrop Research Institute and Division of Rheumatology, Allergy and Immunology, Department of Medicine, Winthrop-University Hospital, 222 Station Plaza North, Suite 502, Mineola, NY 11501, USA

Received 20 April 2013; Revised 29 October 2013; Accepted 30 October 2013; Published 23 January 2014

Academic Editor: Marija Mostarica-Stojković

Copyright © 2014 Iryna Voloshyna et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Iryna Voloshyna, Sangeetha Seshadri, Kamran Anwar, et al., “Infliximab Reverses Suppression of Cholesterol Efflux Proteins by TNF-α: A Possible Mechanism for Modulation of Atherogenesis,” BioMed Research International, vol. 2014, Article ID 312647, 8 pages, 2014. doi:10.1155/2014/312647